VECT

HEALTHCARE

VectivBio Holding AG

—PRE

Live · NASDAQ · May 8, Close

AI Insight

What's Moving VECT Today?

No stock-specific AI insight has been generated for VECT yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap$1.1B

P/E Ratio—

EPS$-2.10

Dividend Yield—

Dividend / Share—

ROE-0.6%

Profit Margin—

Debt / Equity—

Trading

Volume—

Avg Volume (10D)—

Shares Outstanding62.8M

VECT News

No news articles found for VECT yet.

Price Data

Open—

Previous Close—

Day High—

Day Low—

52 Week High$0.00

52 Week Low$0.00

Fundamentals

Market Cap$1.1B

P/E Ratio—

EPS$-2.10

Dividend Yield—

Dividend / Share—

ROE-0.6%

Profit Margin—

Debt / Equity—

Trading

Volume—

Avg Volume (10D)—

Shares Outstanding62.8M

About VectivBio Holding AG

VectivBio Holding AG, a clinical-stage biopharmaceutical company, focuses on the discovery, development and commercialization of treatments for rare conditions. The company is headquartered in Basel, Switzerland.

vectivbio.com

Listed April 8, 2021

HEALTHCAREPHARMACEUTICALS

Company Details

Security TypeStock

ExchangeNASDAQ

CurrencyUSD

Round Lot—

SICPHARMACEUTICALS

CIK—

Composite FIGI—

Share Class FIGI—